Spots Global Cancer Trial Database for Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)

Study Description

Brief Summary: The results of the study will permit to set up a standardized and validated procedure of pain management authorizing medical and paramedical staff of brachytherapy department to handle pain and in this way to improve the quality of life of the patients.

Detailed Description: * Selection criteria validation * Patient information and collection of a signed informed consent * Randomization * Completion of HADS questionnaire * Day 1 = Begin of analgesic treatment / brachytherapy * T-30= 30 minutes before the operative procedure, IV administration of the analgesic treatment (Arm A or B) by the anesthetist * T0= end of the operative procedure under general anesthesia * T4, T8, and T12 = 4, 8 and 12 hours after T0: evaluation of pain level. If pain level ≥ 4: 1. paracetamol-codeine (Arms A and B) and continuation of ketoprofen (Arm B). Then, if persistence of pain : 2. paracetamol and morphine (Arms A and B) * Day 2 to Day 30: At home or during hospital stay: Pain assessment twice a day by the patient until absence of pain during 2 consecutive days * Day 3 and Day 15: Pain assessment or phone interview by the algologist of the investigation center ; completion of a HADS questionnaire on Day 3 * Day 30= End of study: Pain assessment by the algologist of the investigation center and HADS questionnaire In any case, pain assessment must be done until absence of pain during 2 consecutive days

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Contact Details

Useful links and downloads for this trial